138 related articles for article (PubMed ID: 37039952)
21. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
[TBL] [Abstract][Full Text] [Related]
22. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
23. 5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
Müther M; Koch R; Weckesser M; Sporns P; Schwindt W; Stummer W
Neurosurgery; 2019 Dec; 85(6):E1020-E1029. PubMed ID: 31215632
[TBL] [Abstract][Full Text] [Related]
24. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
25. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
[TBL] [Abstract][Full Text] [Related]
26. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study.
Miwa K; Shinoda J; Yano H; Okumura A; Iwama T; Nakashima T; Sakai N
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1457-62. PubMed ID: 15377696
[TBL] [Abstract][Full Text] [Related]
27. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
Lohmann P; Stavrinou P; Lipke K; Bauer EK; Ceccon G; Werner JM; Neumaier B; Fink GR; Shah NJ; Langen KJ; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):591-602. PubMed ID: 30327856
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
29. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
[TBL] [Abstract][Full Text] [Related]
30. Integration of [11C]methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumors in children.
Pirotte B; Goldman S; Van Bogaert P; David P; Wikler D; Rorive S; Brotchi J; Levivier M
Neurosurgery; 2005 Jul; 57(1 Suppl):128-39; discussion 128-39. PubMed ID: 15987579
[TBL] [Abstract][Full Text] [Related]
31. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
32. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
[TBL] [Abstract][Full Text] [Related]
33. Preoperative 11 C-Methionine PET-MRI in Pediatric Infratentorial Tumors.
Beuriat PA; Flaus A; Portefaix A; Szathmari A; Janier M; Hermier M; Lorthois-Ninou S; Scheiber C; Isal S; Costes N; Merida I; Lancelot S; Vasiljevic A; Leblond P; Faure Conter C; Saunier C; Kassai B; Vinchon M; Di Rocco F; Mottolese C
Clin Nucl Med; 2024 May; 49(5):381-386. PubMed ID: 38498623
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
[TBL] [Abstract][Full Text] [Related]
35. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
36. Comparison of [
Shymanskaya A; Worthoff WA; Stoffels G; Lindemeyer J; Neumaier B; Lohmann P; Galldiks N; Langen KJ; Shah NJ
Mol Imaging Biol; 2020 Feb; 22(1):198-207. PubMed ID: 30989437
[TBL] [Abstract][Full Text] [Related]
37. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
[TBL] [Abstract][Full Text] [Related]
38. The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A
Kudulaiti N; Zhang H; Qiu T; Lu J; Aibaidula A; Zhang Z; Guan Y; Zhuang D
Mol Imaging; 2019; 18():1536012119894087. PubMed ID: 31889470
[TBL] [Abstract][Full Text] [Related]
39. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
40. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.
Galldiks N; Ullrich R; Schroeter M; Fink GR; Jacobs AH; Kracht LW
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):84-92. PubMed ID: 19662410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
